BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 11979954)

  • 21. Tibolone: a unique version of hormone replacement therapy.
    Swegle JM; Kelly MW
    Ann Pharmacother; 2004 May; 38(5):874-81. PubMed ID: 15026563
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complex endometrial hyperplasia in the context of tibolone administration.
    Kane SC; Quinn MA
    Aust N Z J Obstet Gynaecol; 2009 Jun; 49(3):338-9. PubMed ID: 19566575
    [No Abstract]   [Full Text] [Related]  

  • 23. Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women.
    Bjarnason NH
    Dan Med Bull; 2005 May; 52(2):64-81. PubMed ID: 16009050
    [No Abstract]   [Full Text] [Related]  

  • 24. [Drugs in development for the treatment of osteoporosis:Raloxifene].
    Taga M
    Nihon Rinsho; 2002 Mar; 60 Suppl 3():572-80. PubMed ID: 11979956
    [No Abstract]   [Full Text] [Related]  

  • 25. Effects of tibolone on nuclear receptors in human endometrial cells.
    Zhang W; Mazella J; Kloosterboer HJ; Tseng L
    Am J Obstet Gynecol; 2006 Jul; 195(1):97-102. PubMed ID: 16813748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The treatment of osteoporosis. Antiresorptive therapy.
    Miller PD
    Clin Lab Med; 2000 Sep; 20(3):603-22, viii. PubMed ID: 10986624
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tibolone in postmenopausal women: a review based on recent randomised controlled clinical trials.
    Biglia N; Maffei S; Lello S; Nappi RE
    Gynecol Endocrinol; 2010 Nov; 26(11):804-14. PubMed ID: 20586550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alternatives to hormone replacement therapy: raloxifene and tibolone].
    von Holst T
    Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):205-9. PubMed ID: 10802895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tibolone as an alternative to estrogen for the prevention of postmenopausal osteoporosis in selected postmenopausal women.
    Riggs BL
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2417-8. PubMed ID: 8675553
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention and treatment of osteoporosis.
    Okolo S; Ginsburg J; Hardiman P
    Lancet; 1993 May; 341(8856):1349. PubMed ID: 8098479
    [No Abstract]   [Full Text] [Related]  

  • 31. Tibolone: clinical recommendations and practical guidelines. A report of the International Tibolone Consensus Group.
    Kenemans P; Speroff L;
    Maturitas; 2005 May; 51(1):21-8. PubMed ID: 15883105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Treatment of osteoporosis].
    Lakatos P
    Orv Hetil; 2003 Aug; 144(31):1551-2. PubMed ID: 14502870
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of tibolone and its metabolites on Angiopoietin-1, Tie-2 and tumor necrosis factor-alpha mRNA in Ishikawa cells. Implication for tibolone's effects on the endometrium.
    Mirkin S; Archer DF
    Maturitas; 2007 Aug; 57(4):338-46. PubMed ID: 17478063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emerging therapies for the prevention or treatment of postmenopausal osteoporosis.
    Sato M; Grese TA; Dodge JA; Bryant HU; Turner CH
    J Med Chem; 1999 Jan; 42(1):1-24. PubMed ID: 9888829
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of tibolone on the breast of postmenopausal women.
    Wang PH; Cheng MH; Chao HT; Chao KC
    Taiwan J Obstet Gynecol; 2007 Jun; 46(2):121-6. PubMed ID: 17638619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Tamoxifen and osteoporosis].
    Dunst J
    Strahlenther Onkol; 1995 Feb; 171(2):113-4. PubMed ID: 7863424
    [No Abstract]   [Full Text] [Related]  

  • 37. Tibolone for postmenopausal women: systematic review of randomized trials.
    Modelska K; Cummings S
    J Clin Endocrinol Metab; 2002 Jan; 87(1):16-23. PubMed ID: 11788614
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of tibolone and conventional HRT on the expression of estrogen and progesterone receptors in the breast.
    Ma L; Hofling M; Masironi B; von Schoultz B; Cline JM; Sahlin L
    Maturitas; 2008 Dec; 61(4):345-9. PubMed ID: 18980817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The concept of selective action steroids].
    Jamin C
    Gynecol Obstet Fertil; 2000 Dec; 28(12):931-9. PubMed ID: 11192203
    [No Abstract]   [Full Text] [Related]  

  • 40. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
    Jolly EE; Bjarnason NH; Neven P; Plouffe L; Johnston CC; Watts SD; Arnaud CD; Mason TM; Crans G; Akers R; Draper MW
    Menopause; 2003; 10(4):337-44. PubMed ID: 12851517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.